WallStreetZenWallStreetZen

NASDAQ: HZNP
Horizon Therapeutics Public Ltd Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HZNP past earnings growth

How has HZNP's earnings growth performed historically?
Company
-42.86%
Industry
-7.2%
Market
36.64%
HZNP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HZNP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

HZNP past revenue growth

How has HZNP's revenue growth performed historically?
Company
-4.42%
Industry
-0.1%
Market
13.81%
HZNP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HZNP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HZNP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HZNP earnings and revenue history

Current Revenue
$3.6B
Current Earnings
$438.0M
Current Profit Margin
12%

HZNP Return on Equity

Current Company
8.5%
Current Industry
37.1%
Current Market
22.1%
HZNP's Return on Equity (8.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HZNP announces earnings.

HZNP Return on Assets

Current Company
4.8%
Current Industry
8.5%
HZNP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HZNP Return on Capital Employed

Current Company
6.12%
Current Industry
14.1%
HZNP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HZNP vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HZNP$3.64B$901.54M$438.00M+27.71%+34.31%
BIIB$9.97B$3.71B$2.66B-4.98%+5.48%
GRFS$6.59B$1.31B$226.39M+4.47%-22.28%
OGN$6.17B$1.60B$754.00M-1.26%-34.36%
AMRN$346.27M-$44.75M-$38.30M+11.85%N/A
View Top General Drug Manufacturer Stocks

HZNP earnings dates

Next earnings date
Nov 8, 2023

Horizon Therapeutics Public Co Earnings & Revenue FAQ

What were HZNP's earnings last quarter?

On Invalid Date, Horizon Therapeutics Public Co (NASDAQ: HZNP) reported Q2 2023 earnings per share (EPS) of $0.56, up 107.41% year over year. Total Horizon Therapeutics Public Co earnings for the quarter were $127.07 million. In the same quarter last year, Horizon Therapeutics Public Co's earnings per share (EPS) was $0.27.

If you're new to stock investing, here's how to buy Horizon Therapeutics Public Co stock.

What was HZNP's earnings growth in the past year?

As of Q3 2023, Horizon Therapeutics Public Co's earnings has grown -42.86% year over year. This is 35.66 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of -7.2%. Horizon Therapeutics Public Co's earnings in the past year totalled $438.00 million.

What is HZNP's earnings date?

Horizon Therapeutics Public Co's earnings date is Invalid Date. Add HZNP to your watchlist to be reminded of HZNP's next earnings announcement.

What was HZNP's revenue last quarter?

On Invalid Date, Horizon Therapeutics Public Co (NASDAQ: HZNP) reported Q2 2023 revenue of $944.96 million up 7.82% year over year. In the same quarter last year, Horizon Therapeutics Public Co's revenue was $876.41 million.

What was HZNP's revenue growth in the past year?

As of Q3 2023, Horizon Therapeutics Public Co's revenue has grown -4.42% year over year. This is 4.33 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of -0.1%. Horizon Therapeutics Public Co's revenue in the past year totalled $3.64 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.